Invest
AlphaRose Therapeutics, born from a father's love for his daughter, is pioneering personalized medicine at scale for children with genetic diseases.
Our innovative approach rapidly develops and commercializes treatments for patients who are typically ignored by large pharma.
With over $1 million in funding, our lead product Rosiphersen is advancing towards a clinical trial led by a passionate, experienced team.
We are currently offering a public investment through a Reg CF offering for a limited time.*
*Investments in Regulation Crowdfunding offerings involve significant risk, including the potential for loss of your entire investment. These investments are not FDIC insured and are not a guaranteed way to make money. The SEC does not guarantee the success or value of this offering. This investment may not be suitable for all investors. Please carefully consider the risks and limitations outlined in the offering statement before investing